Company intelligence / Profile preview
Akeso, Inc.
Zhuhai, Guangdong, Chinaakesobio.com ↗
- Ownership
- Public · AKESF
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
Akeso has achieved commercial approval for its lead bispecific antibody Cadonilimab for cervical cancer in China. Multiple other programs are advancing through Phase II and III trials targeting solid tumors and autoimmune diseases. The company is recognized as a leader in bispecific immunotherapy innovation with a robust clinical pipeline.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodies (mAbs)Bispecific antibodiesImmunotherapiesAntibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
53 assets52 more assets in the full pipeline.
Request access →03
Partnerships
Sino Biopharmaceutical LimitedTianjin Chia Tai Tianqing Pharmaceutical GroupBoehringer IngelheimTigermedCStone PharmaceuticalsKintor PharmaNanjing Leads Biolabs Co., Ltd.Sorrento Therapeutics
04
Financials
- Market cap
- $484.6M
- Total revenue
- $160.2M
- Enterprise value
- $396.6M
Beyond the preview
Go deeper on Akeso, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akeso, Inc..